Revista Espanola de Quimioterapia

Papers
(The H4-Index of Revista Espanola de Quimioterapia is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Cefiderocol65
47
Evaluation of two immunocromatographic tests for the detection of antibodies against SARS-CoV-245
39
COVID-19 in donation and transplant35
Mechanical ventilation associated pneumonia during ECMO therapy. A challenge for the Intensive Care physician26
Prevalence of SARS-CoV-2 infection during the first wave of the pandemic among health and non-health personnel of the General Hospital of Segovia, Castilla y León25
Successful rezafungin treatment of an azole-resistant Candida parapsilosis vascular graft infection19
Systemic absorption of liposomal inhaled amikacin in the treatment of resistant Mycobacterium avium: beyond expectations19
Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences18
Usefulness of monocyte distribution width (MDW) as a sepsis biomarker18
COVID-19: Impact on prescribing and antimicrobial resistance18
Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain17
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project17
Is Propionimicrobium lymphophilum a new urinary tract infection cause?16
Influence of epidemiological and clinical factors in the reactogenicity to Comirnaty® vaccine in health care workers of a Spanish university teaching hospital (COVIVAC study)16
Persistence and viability of SARS-CoV-2 in primary infection and reinfections16
0.02609395980835